神经内视镜市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球神经内视镜市场价值为 1.585 亿美元，预计在 2025 年至 2034 年期间的复合年增长率为 5.7%，这得益于脑肿瘤发病率的上升以及对微创神经外科手术的偏好日益增加。随着全球神经系统疾病负担不断增加，神经内视镜检查正成为关键的解决方案，为治疗各种脑部疾病提供更精确、侵入性更小的选择。随着影像和内视镜技术的进步，神经内视镜技术使外科医生能够以更好的可视化和准确性导航复杂的脑结构，从而减少患者的创伤，缩短恢復期，并改善手术效果。

对神经系统疾病（包括神经胶质瘤和脑下垂体腺瘤）的早期诊断和有效治疗的需求不断增长，进一步扩大了对先进神经内视镜设备的需求。此外，人口老化更容易患神经系统疾病，这也推动了市场需求，而内视镜工具和配件的不断创新有助于扩大全球神经内视镜手术的范围。医疗机构越来越多地投资于整合高清光学和机器人辅助的尖端设备，使神经外科医生能够以更高的安全性和效率执行复杂的手术。

市场分为硬性神经内视镜和软性神经内视镜，其中硬性神经内视镜占据最大份额的收入。 2024 年，硬质神经内视镜市场收入达到 1.041 亿美元，反映了其在复杂神经外科手术中的广泛应用。硬质神经内视镜因其在肿瘤切除术、脑室造口术和脑室内手术等手术过程中出色的可视化能力和稳定性而受到青睐。其坚固的设计和高精度使其成为解决手术准确性至关重要的复杂神经系统病例的必需品。随着越来越多的医疗保健提供者专注于以最少的併发症实现更好的患者治疗效果，硬性神经内视镜的采用率持续上升。

神经内视镜也根据可用性分为可重复使用和一次性类型，其中可重复使用的神经内视镜在 2024 年产生 1.372 亿美元的收入。这些设备因其成本效益和耐用性而越来越受到青睐，尤其是在高容量手术中心。可重复使用的神经内视镜可显着降低长期营运成本，并透过最大限度地减少医疗废物，满足医疗保健行业日益重视的可持续性。医院和专科诊所正在采用可重复使用的设备来平衡临床表现和环境责任，使其成为全球机构的首选。

从区域来看，美国神经内视镜市场在 2024 年达到 5,610 万美元，预计 2025 年至 2034 年的复合年增长率为 4.8%。神经系统疾病盛行率的上升，加上对微创干预的需求，正在推动美国市场的成长。机器人辅助神经内视镜和先进影像解决方案（如 4K 超高清视觉化系统）的日益融合有望彻底改变神经外科实践，提高精确度和病患治疗效果。随着美国医疗保健提供者不断拥抱技术进步，预计未来十年对神经内视镜设备的需求将出现强劲增长。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 脑瘤病例不断增加
    • 微创外科手术需求激增
    • 神经外科的技术进步
    • 老年人口不断增加
  • 产业陷阱与挑战
    • 设备和手术费用高昂
• 成长潜力分析
• 监管格局
• 技术格局
• 报销场景
• 差距分析
• 波特的分析
• PESTEL分析
• 未来市场趋势

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 硬质神经内视镜
  • 硬质纤维镜
  • 硬式视讯内视镜
• 柔性神经内视镜

第六章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 经鼻神经内视镜检查
• 脑室内神经内视镜检查
• 经颅神经内视镜检查

第七章：市场估计与预测：按可用性，2021 - 2034 年

• 主要趋势
• 可重复使用的神经内视镜
• 免洗神经内视镜

第 8 章：市场估计与预测：按患者，2021 年至 2034 年

• 主要趋势
• 成人
• 儿科

第九章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 诊断中心
• 其他最终用途

第十章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：公司简介

• Ackermann
• adeor MEDICAL
• ADVANCED BIOLOGICS
• Advin Health care
• B. Braun
• Chongqing Xishan Science & Technology
• CLARUS MEDICAL
• joimax
• KARL STORZ
• Machida
• SCHINDLER ENDOSKOPIE TECHNOLOGIE

The Global Neuroendoscopy Market was valued at USD 158.5 million in 2024 and is poised to grow at a CAGR of 5.7% between 2025 and 2034, driven by the increasing incidence of brain tumors and the rising preference for minimally invasive neurosurgical procedures. As the global burden of neurological disorders continues to surge, neuroendoscopy is emerging as a critical solution, offering more precise and less invasive options for treating a variety of brain conditions. With advancements in imaging and endoscopic technology, neuroendoscopy allows surgeons to navigate complex brain structures with improved visualization and accuracy, resulting in reduced patient trauma, shorter recovery periods, and better surgical outcomes.

The growing demand for early diagnosis and effective treatment of neurological diseases, including gliomas and pituitary adenomas, is further amplifying the need for advanced neuroendoscopic devices. Additionally, an aging population, which is more prone to neurological conditions, is driving market demand, while ongoing innovations in endoscopic tools and accessories are helping to broaden the scope of neuroendoscopic procedures worldwide. Healthcare facilities are increasingly investing in cutting-edge devices that integrate high-definition optics and robotic assistance, enabling neurosurgeons to perform intricate surgeries with enhanced safety and efficiency.

The market is segmented into rigid and flexible neuroendoscopes, with rigid neuroendoscopes holding the largest share of the revenue. In 2024, the rigid neuroendoscope segment generated USD 104.1 million, reflecting their widespread use in complex neurosurgical procedures. Rigid neuroendoscopes are preferred for their superior visualization capabilities and stability during surgeries such as tumor resections, ventriculostomies, and intraventricular procedures. Their robust design and high precision make them essential for addressing challenging neurological cases where surgical accuracy is paramount. As more healthcare providers focus on achieving better patient outcomes with minimal complications, the adoption of rigid neuroendoscopes continues to rise.

Neuroendoscopes are also classified based on usability into reusable and disposable types, with reusable neuroendoscopes generating USD 137.2 million in 2024. These devices are increasingly favored for their cost-efficiency and durability, especially in high-volume surgical centers. Reusable neuroendoscopes significantly reduce operational costs over time and align with the growing emphasis on sustainability within the healthcare sector by minimizing medical waste. Hospitals and specialty clinics are adopting reusable devices to balance clinical performance with environmental responsibility, making them a top choice for institutions worldwide.

In regional terms, the U.S. Neuroendoscopy Market reached USD 56.1 million in 2024 and is projected to expand at a CAGR of 4.8% from 2025 to 2034. The rising prevalence of neurological disorders, coupled with the demand for minimally invasive interventions, is propelling market growth in the U.S. The increasing integration of robotic-assisted neuroendoscopy and advanced imaging solutions, such as 4K ultra-high-definition visualization systems, is expected to revolutionize neurosurgical practices, improving precision and patient outcomes. As U.S. healthcare providers continue to embrace technological advancements, the demand for neuroendoscopic devices is anticipated to witness robust growth over the next decade.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of brain tumor cases
    • 3.2.1.2 Surging demand for minimally invasive surgical procedures
    • 3.2.1.3 Technological advancements in neurosurgery
    • 3.2.1.4 Growing elderly population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with devices and surgeries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Rigid neuroendoscopes
  • 5.2.1 Rigid fiberscopes
  • 5.2.2 Rigid videoscopes
• 5.3 Flexible neuroendoscopes

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Transnasal neuroendoscopy
• 6.3 Intraventricular neuroendoscopy
• 6.4 Transcranial neuroendoscopy

Chapter 7 Market Estimates and Forecast, By Usability, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Reusable neuroendoscopes
• 7.3 Disposable neuroendoscopes

Chapter 8 Market Estimates and Forecast, By Patient, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Adult
• 8.3 Pediatric

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Ambulatory surgical centers
• 9.4 Diagnostic centers
• 9.5 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Ackermann
• 11.2 adeor MEDICAL
• 11.3 ADVANCED BIOLOGICS
• 11.4 Advin Health care
• 11.5 B. Braun
• 11.6 Chongqing Xishan Science & Technology
• 11.7 CLARUS MEDICAL
• 11.8 joimax
• 11.9 KARL STORZ
• 11.10 Machida
• 11.11 SCHINDLER ENDOSKOPIE TECHNOLOGIE